143 related articles for article (PubMed ID: 29763933)
1. The Calcium-Sensing Receptor Gene Polymorphism rs1801725 and Calcium-Related Phenotypes in Hemodialysis Patients.
Grzegorzewska AE; Bednarski D; Świderska M; Mostowska A; Jagodziński PP
Kidney Blood Press Res; 2018; 43(3):719-734. PubMed ID: 29763933
[TBL] [Abstract][Full Text] [Related]
2. Associations of the calcium-sensing receptor gene CASR rs7652589 SNP with nephrolithiasis and secondary hyperparathyroidism in haemodialysis patients.
Grzegorzewska AE; Paciorkowski M; Mostowska A; Frycz B; Warchoł W; Stolarek I; Figlerowicz M; Jagodziński PP
Sci Rep; 2016 Oct; 6():35188. PubMed ID: 27739473
[TBL] [Abstract][Full Text] [Related]
3. Calcium-sensing receptor gene (CASR) polymorphisms and CASR transcript level concerning dyslipidemia in hemodialysis patients: a cross-sectional study.
Grzegorzewska AE; Frycz BA; Świderska M; Niepolski L; Mostowska A; Jagodziński PP
BMC Nephrol; 2019 Nov; 20(1):436. PubMed ID: 31775661
[TBL] [Abstract][Full Text] [Related]
4. The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Ngamkam J; Vadcharavivad S; Areepium N; Auamnoy T; Takkavatakarn K; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
Sci Rep; 2021 Sep; 11(1):18006. PubMed ID: 34504264
[TBL] [Abstract][Full Text] [Related]
5. Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis.
Moe SM; Wetherill L; Decker BS; Lai D; Abdalla S; Long J; Vatta M; Foroud TM; Chertow GM
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1128-1138. PubMed ID: 28630081
[TBL] [Abstract][Full Text] [Related]
6. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
7. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267
[TBL] [Abstract][Full Text] [Related]
8. Cinacalcet upregulates calcium-sensing receptors of parathyroid glands in hemodialysis patients.
Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
Am J Nephrol; 2013; 37(5):405-12. PubMed ID: 23594726
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients.
Eren PA; Turan K; Berber I; Canbakan M; Kara M; Tellioglu G; Bugan U; Sevinç C; Turkmen F; Titiz MI
Clin Nephrol; 2009 Aug; 72(2):114-21. PubMed ID: 19640368
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.
Lindberg JS; Culleton B; Wong G; Borah MF; Clark RV; Shapiro WB; Roger SD; Husserl FE; Klassen PS; Guo MD; Albizem MB; Coburn JW
J Am Soc Nephrol; 2005 Mar; 16(3):800-7. PubMed ID: 15689407
[TBL] [Abstract][Full Text] [Related]
11. Calcium-sensing receptor gene polymorphism (rs7652589) is associated with calcium nephrolithiasis in the population of Yi nationality in Southwestern China.
Li H; Zhang J; Long J; Shi J; Luo Y
Ann Hum Genet; 2018 Sep; 82(5):265-271. PubMed ID: 29682741
[TBL] [Abstract][Full Text] [Related]
12. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.
Quarles LD; Sherrard DJ; Adler S; Rosansky SJ; McCary LC; Liu W; Turner SA; Bushinsky DA
J Am Soc Nephrol; 2003 Mar; 14(3):575-83. PubMed ID: 12595492
[TBL] [Abstract][Full Text] [Related]
13. CASR rs1801725 polymorphism is associated with the risk and prognosis of colorectal cancer: A case-control study.
Diao YE; Xu Q
J Clin Lab Anal; 2020 Nov; 34(11):e23463. PubMed ID: 32648293
[TBL] [Abstract][Full Text] [Related]
14. The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism.
Messa P; Macário F; Yaqoob M; Bouman K; Braun J; von Albertini B; Brink H; Maduell F; Graf H; Frazão JM; Bos WJ; Torregrosa V; Saha H; Reichel H; Wilkie M; Zani VJ; Molemans B; Carter D; Locatelli F
Clin J Am Soc Nephrol; 2008 Jan; 3(1):36-45. PubMed ID: 18178780
[TBL] [Abstract][Full Text] [Related]
15. Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients.
Wang L; Widatalla SE; Whalen DS; Ochieng J; Sakwe AM
BMC Cancer; 2017 Aug; 17(1):511. PubMed ID: 28764683
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients.
Jeong S; Kim IW; Oh KH; Han N; Joo KW; Kim HJ; Oh JM
Drug Des Devel Ther; 2016; 10():2211-25. PubMed ID: 27468225
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone gene rs6256 and calcium sensing receptor gene rs1801725 variants are not associated with susceptibility to colorectal cancer in Iran.
Mahmoudi T; Karimi K; Arkani M; Farahani H; Nobakht H; Dabiri R; Asadi A; Zali MR
Asian Pac J Cancer Prev; 2014; 15(15):6035-9. PubMed ID: 25124570
[TBL] [Abstract][Full Text] [Related]
18. A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM).
Wetmore JB; Gurevich K; Sprague S; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1031-40. PubMed ID: 25904755
[TBL] [Abstract][Full Text] [Related]
19. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
